GABARAP sequesters the FLCN-FNIP tumor suppressor complex to couple autophagy with lysosomal biogenesis

Jonathan M. Goodwin(Casma Therapeutics (United States)), Ward G. Walkup(Casma Therapeutics (United States)), Kirsty M. Hooper(Babraham Institute), Taoyingnan Li(University of Toronto), Chieko Kishi‐Itakura(Babraham Institute), Aylwin Ng(Casma Therapeutics (United States)), Timothy Z. Lehmberg(Casma Therapeutics (United States)), Archana Jha(Casma Therapeutics (United States)), Sravya Kommineni(Casma Therapeutics (United States)), Katherine Fletcher(Babraham Institute), Jorge García‐Fortanet(Casma Therapeutics (United States)), Yaya Fan, Qing Tang, Menghao Wei, Asmita Agrawal(Spicer Adventist University), Sagar R. Budhe(Spicer Adventist University), Sreekanth R. Rouduri(Spicer Adventist University), Dan Baird(Casma Therapeutics (United States)), Jeff Saunders(Casma Therapeutics (United States)), Janna Kiselar(Abterra Biosciences (United States)), Mark R. Chance(Abterra Biosciences (United States)), Andrea Ballabio(Baylor College of Medicine), B.A. Appleton(Casma Therapeutics (United States)), John H. Brumell(University of Toronto), Oliver Florey(Babraham Institute), Leon O. Murphy(Casma Therapeutics (United States))
Science Advances
October 1, 2021
Cited by 124Open Access
Full Text

Abstract

-induced xenophagy, the membrane conjugation of GABARAP, but not LC3, is required for activation of TFEB/TFE3 to control lysosomal capacity. GABARAP directly binds to a previously unidentified LC3-interacting motif (LIR) in the FLCN/FNIP tumor suppressor complex and mediates sequestration to GABARAP-conjugated membrane compartments. This disrupts FLCN/FNIP GAP function toward RagC/D, resulting in impaired substrate-specific mTOR-dependent phosphorylation of TFEB. Thus, the GABARAP-FLCN/FNIP-TFEB axis serves as a molecular sensor that coordinates lysosomal homeostasis with perturbations and cargo flux within the autophagy-lysosomal network.


Related Papers